ZBH Net income
Net income at Zimmer Biomet fell to $705M in fiscal 2025, from $904M in 2024.
Net income attributable to the parent / common stockholders, as filed.
SOURCE: us-gaap:NetIncomeLoss · EDGAR CompanyFacts · CIK 1136869 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$705M
FY2024 $904M
HIGH$1.0B FY2023
LOW$231M FY2022
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Net income | Change |
|---|---|---|
| FY2025 | $705M | $-199M |
| FY2024 | $904M | $-120M |
| FY2023 | $1.0B | +$793M |
| FY2022 | $231M | $-170M |
| FY2021 | $402M | — |
More SAME DATA, OTHER VIEWS
Net income across coverage → · ZBH company view →
Revenue · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.